Royalty Pharma plc - Ordinary Shares - Class A

NASDAQ:RPRX   3:59:51 PM EDT
40.21
+0.47 (+1.18%)
Earnings Announcements

Royalty Pharma Reports First Quarter 2022 Results

Published: 05/05/2022 11:20 GMT
Royalty Pharma plc - Ordinary Shares - Class A (RPRX) - Royalty Pharma Reports First Quarter 2022 Results.
Royalty Pharma - 2022 Guidance Reaffirmed: Adjusted Cash Receipts Expected to Be $2,225 to $2,300 Million.
Royalty Pharma - Qtrly Total Income and Other Revenues $562 Million Versus $573 Million.
Revenue is expected to be $556.93 Million
Adjusted EPS is expected to be $0.79

Next Quarter Revenue Guidance is expected to be $577.31 Million
Next Quarter EPS Guidance is expected to be $0.69

More details on our Analysts Page.